Complete Cost Breakdown: Wegovy vs Mounjaro Without Surprises
Why Wegovy vs Mounjaro Cost Transparency Matters
When comparing Wegovy vs Mounjaro cost online, many patients experience checkout shock from hidden fees. Traditional online pharmacies often advertise low medication prices, then add consultation fees (£25-£50), prescription charges (£10-£15), or admin costs at the final step. EverydayMeds eliminates this frustration with radical price transparency. Our displayed prices include absolutely everything needed for your weight management journey.
This transparent approach helps you accurately compare Wegovy vs Mounjaro cost without mathematical guesswork. Whether you choose semaglutide (Wegovy) or tirzepatide (Mounjaro), you'll pay exactly what's displayed — no more, no less. Both prescription-only medicines require clinical assessment and prescriber approval, costs that are fully incorporated into our pricing structure from day one.
Complete Wegovy vs Mounjaro Cost Breakdown
Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Mounjaro follows a similar pricing structure, ensuring fair comparison between treatments. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Both medications require identical dose escalation schedules over 16 weeks, meaning the total cost comparison for Wegovy vs Mounjaro remains equivalent. Our bundled options like the Intro Trio (£299.99) provide three months of step-up dosing in a single order, offering convenience and supply security. These bundles maintain the same transparent pricing philosophy — what you see includes everything.
Clinical Evidence Supporting Wegovy vs Mounjaro Cost Considerations
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). The STEP trial programme demonstrated sustained weight management when combined with reduced-calorie diet and increased physical activity. Mounjaro's SURMOUNT trials showed comparable efficacy with its dual GIP/GLP-1 mechanism.
Both treatments require long-term commitment for maintained results, making cost transparency crucial for treatment planning. The SELECT cardiovascular outcomes trial demonstrated Wegovy's 20% reduction in major cardiovascular events, potentially offering additional value beyond weight management. These clinical benefits help justify the investment when comparing Wegovy vs Mounjaro cost against potential health improvements.
How Wegovy Works for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. This prescription-only medicine works by reducing appetite and promoting feelings of satisfaction after smaller meals, potentially helping patients consume fewer calories naturally. The medication acts on brain appetite centres, which may reduce food cravings and emotional eating patterns. Once-weekly injections using the FlexTouch pen provide consistent hormone levels throughout the week. Wegovy must be used alongside a reduced-calorie diet and increased physical activity for optimal effectiveness.
Streamlined Ordering Process with No Hidden Costs
Our transparent Wegovy vs Mounjaro cost structure extends through the entire ordering process. Complete our 3-minute online clinical assessment, then await prescriber review (standard 3 working days, express 24 hours available). Once approved, your medication ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. All these services — assessment, prescribing, and delivery — are included in the displayed price. No additional charges appear at checkout, ensuring you can budget accurately for your weight management treatment.
Storage and Practical Considerations
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for 6 weeks at room temperature versus Mounjaro's 21-day limit. This advantage affects long-term costs by reducing medication waste from storage errors. Both treatments use pre-filled injection pens and require dose escalation from starter to maintenance levels. Store in the fridge at 2-8°C before first use, then follow the FlexTouch pen's easy injection protocol. The dose escalation schedule is mandatory for both medications, preventing cost-saving shortcuts that might compromise safety or effectiveness.
Real-World Wegovy vs Mounjaro Cost Impact
Beyond sticker price comparison, consider the total cost of ownership when evaluating Wegovy vs Mounjaro cost options. Wegovy's 6-week room temperature stability reduces replacement costs from accidental temperature exposure during travel or power outages. The medication's established NICE approval (TA875) provides clearer pathway for potential NHS funding in specialist weight management programmes.
Both treatments represent significant monthly investments, making transparent pricing essential for financial planning. Hidden fees from other pharmacies can add £30-£65 per transaction, substantially impacting your annual treatment budget. EverydayMeds' no-hidden-fees approach ensures accurate cost forecasting throughout your weight management journey.
Complete Your Order with Confidence
Start your transparent Wegovy vs Mounjaro cost comparison today at https://everydaymeds.co.uk/collections/wegovy. Use code FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our all-inclusive pricing from £79.99. Our GPhC-registered pharmacy (#9012878) ensures safe, legal access to both prescription-only medicines with complete clinical oversight. The displayed price includes everything — clinical assessment, prescriber review, prescription, medication, and next-day delivery. No hidden fees, no surprise charges, no checkout disappointments. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment suits your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
